HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 100 filers reported holding HARVARD BIOSCIENCE INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,902,581 | +31.6% | 1,439,450 | +0.7% | 0.24% | +32.8% |
| Q1 2023 | $6,006,634 | +48.3% | 1,430,151 | -2.2% | 0.18% | +47.6% |
| Q4 2022 | $4,051,006 | +6.0% | 1,462,457 | -2.1% | 0.12% | -0.8% |
| Q3 2022 | $3,823,000 | -30.7% | 1,493,269 | -2.6% | 0.12% | -33.5% |
| Q2 2022 | $5,518,000 | -39.0% | 1,532,693 | +5.2% | 0.19% | -16.4% |
| Q1 2022 | $9,046,000 | -22.6% | 1,456,749 | -12.1% | 0.22% | -6.6% |
| Q4 2021 | $11,688,000 | +6.0% | 1,657,823 | +4.9% | 0.24% | +15.3% |
| Q3 2021 | $11,026,000 | -14.0% | 1,579,655 | +2.6% | 0.21% | -12.6% |
| Q2 2021 | $12,825,000 | +54.6% | 1,539,560 | +1.3% | 0.24% | +35.8% |
| Q1 2021 | $8,296,000 | +26.9% | 1,519,323 | -0.3% | 0.18% | +19.7% |
| Q4 2020 | $6,535,000 | +23.6% | 1,523,352 | -13.3% | 0.15% | -17.9% |
| Q3 2020 | $5,289,000 | -1.6% | 1,757,176 | +1.4% | 0.18% | -7.7% |
| Q2 2020 | $5,373,000 | +31.7% | 1,733,143 | -6.1% | 0.19% | -11.8% |
| Q1 2020 | $4,080,000 | -29.0% | 1,846,148 | -2.1% | 0.22% | -17.0% |
| Q4 2019 | $5,749,000 | +5.5% | 1,884,833 | +6.4% | 0.26% | -11.7% |
| Q3 2019 | $5,449,000 | +194.9% | 1,771,964 | +91.8% | 0.30% | +229.7% |
| Q2 2019 | $1,848,000 | -56.5% | 923,773 | -6.4% | 0.09% | -60.1% |
| Q1 2019 | $4,253,000 | +22.5% | 986,701 | -9.6% | 0.23% | -7.3% |
| Q4 2018 | $3,472,000 | -40.7% | 1,091,683 | -2.0% | 0.25% | -22.4% |
| Q3 2018 | $5,851,000 | +1.7% | 1,114,490 | +3.6% | 0.32% | -8.6% |
| Q2 2018 | $5,753,000 | +19.7% | 1,075,363 | +11.8% | 0.35% | 0.0% |
| Q1 2018 | $4,808,000 | +55.7% | 961,647 | +2.8% | 0.35% | +42.8% |
| Q4 2017 | $3,088,000 | +53.2% | 935,717 | +74.1% | 0.24% | +44.6% |
| Q3 2017 | $2,016,000 | +166.0% | 537,467 | +80.7% | 0.17% | +140.0% |
| Q2 2017 | $758,000 | -71.3% | 297,412 | -70.7% | 0.07% | -73.6% |
| Q1 2017 | $2,641,000 | -43.7% | 1,015,728 | -33.9% | 0.26% | +64.6% |
| Q4 2016 | $4,690,000 | +30.5% | 1,537,815 | +16.4% | 0.16% | +36.4% |
| Q3 2016 | $3,593,000 | -2.4% | 1,321,115 | +2.7% | 0.12% | -11.9% |
| Q2 2016 | $3,680,000 | -9.2% | 1,286,725 | -4.1% | 0.13% | -8.8% |
| Q1 2016 | $4,052,000 | -17.4% | 1,341,795 | -5.1% | 0.15% | -13.0% |
| Q4 2015 | $4,904,000 | -23.8% | 1,413,215 | -17.0% | 0.17% | -15.1% |
| Q3 2015 | $6,438,000 | -35.5% | 1,703,046 | -2.8% | 0.20% | -29.7% |
| Q2 2015 | $9,986,000 | +5.5% | 1,751,946 | +7.7% | 0.28% | +4.4% |
| Q1 2015 | $9,467,000 | +1.7% | 1,626,636 | -1.0% | 0.27% | -0.4% |
| Q4 2014 | $9,312,000 | +38.4% | 1,642,276 | -0.1% | 0.27% | +30.8% |
| Q3 2014 | $6,726,000 | -13.5% | 1,644,590 | -3.7% | 0.21% | -8.4% |
| Q2 2014 | $7,772,000 | -6.6% | 1,708,216 | -2.7% | 0.23% | +1.3% |
| Q1 2014 | $8,323,000 | +2.7% | 1,755,916 | +1.9% | 0.22% | +7.7% |
| Q4 2013 | $8,103,000 | +52.6% | 1,723,960 | +70.8% | 0.21% | +47.5% |
| Q3 2013 | $5,309,000 | +15.2% | 1,009,325 | +3.0% | 0.14% | +6.0% |
| Q2 2013 | $4,607,000 | – | 980,305 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| B. Riley Asset Management, LLC | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |